Latest Distribution Agreements News

Audeara Ltd reported a strong Q2 FY26 with revenues up 274% year-on-year, securing key regulatory approval in China and expanding its global licensing footprint.

ARB Corporation’s half-year results reveal a modest sales dip driven by Australian OEM challenges, while robust US export growth offers a silver lining.

Mastermyne Group has extended its exclusive distribution agreement with Jennmar Holdings for critical strata consolidation products by a decade, locking in supply until 2047. This move strengthens its foothold in the Australian underground coal mining sector.

Tetratherix has inked a global exclusive distribution agreement with healthcare giant Henry Schein, paving the way for its first bone regeneration product, Tegenix, to enter major markets in 2026. Concurrently, the company has begun building an advanced manufacturing facility to meet expected global demand.

Wellnex Life reports a $2.4 million EBITDA improvement in H1 FY26 and reaches breakeven by Q2, supported by strong Pain Away sales and expanded distribution.

Osteopore Limited has secured an exclusive multi-year distribution agreement with Majeton to commercialise its dental and maxillofacial products in China, Hong Kong, and Macau, marking a major step in its Asia-Pacific expansion.

Merino & Co. has secured a significant follow-up order from its Shanghai-based omni-channel distributor, reinforcing its expanding footprint in China’s retail and digital markets.

Wellnex Life reports encouraging early results from its turnaround strategy, posting a modest EBITDA profit and robust sales growth for its Pain Away brand.

Merino & Co. has secured a significant new order from its Shanghai distribution partner, reinforcing its expanding footprint in China’s luxury apparel market and validating its strategic growth plans.

OMG Group has expanded its Blue Dinosaur protein bar distribution to 300 Metro Petroleum stores, reinforcing its growing presence in petrol and convenience retail channels ahead of the summer season.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Australian Vintage Limited has secured a five-year distribution agreement to represent Invivo's wine portfolio in the UK and Ireland, promising significant revenue and volume growth.